LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose

Mingfeng Shao1, Ziqiang Yu1, Jianan Zou1

  • 1Department of Urology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei City, Anhui Province 230031, People's Republic of China.

Abstract

Insights

Long non-coding RNA SNHG16 is overexpressed in prostate carcinoma, correlating with glucose transporter 1 (GLUT-1) and inhibiting cancer cell proliferation. SNHG16 may be a therapeutic target for prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Long non-coding RNA SNHG16 (lncRNA-SNHG16) is implicated as an oncogene in various cancers.
  • Its specific role in prostate carcinoma pathogenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and function of lncRNA-SNHG16 in prostate carcinoma.
  • To determine the relationship between lncRNA-SNHG16, glucose transporter 1 (GLUT-1), and prostate cancer cell proliferation.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) was used to analyze lncRNA-SNHG16 and GLUT-1 expression in prostate carcinoma and normal tissues.
  • In vitro transfections and cell proliferation assays were conducted to assess gene interactions and cellular behavior.
  • RNA interference (siRNA) was employed to silence lncRNA-SNHG16 expression.

Main Results:

  • lncRNA-SNHG16 overexpression significantly differentiated prostate carcinoma from normal tissues.
  • Positive correlation observed between lncRNA-SNHG16 and GLUT-1 mRNA levels in prostate carcinoma.
  • Silencing lncRNA-SNHG16 reduced GLUT-1 expression, glucose uptake, and inhibited prostate cancer cell proliferation without affecting normal prostate cells.

Conclusions:

  • lncRNA-SNHG16 plays a crucial role in promoting prostate carcinoma progression.
  • lncRNA-SNHG16 emerges as a potential therapeutic target for prostate cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K